Monroe Biomedical Research - Illustration - therapeutic areas - ASTHMA

Join this Asthma Study.

Over 25 million Americans suffer from Asthma. Its through studies like this that novel therapies are developed to improve their quality of life!

If you’re at least 12 years and have been diagnosed with Asthma for at least 6 months, you may be eligible for this clinical research study.

dialogue icon

World-class
Medical Oversight

  • 24-hour access to MBR’s doctors/medical staff.
  • World class medical oversight.
  • Free of Charge!
like icon

Free of Charge!

  • Insurance is NOT required to participate.
  • Free services include:
    – Study related medication
    – Doctor’s visits
    – Physical exams
    – Testing
coins icon

Receive a stipend for participating

  • Compensation for trial participation varies by study
  • Those who qualify and choose to participate may receive a stipend between $750 and $1,125
  • See below

Monroe Biomedical Research - Illustration - therapeutic areas - ASTHMA

“It’s through research like this that we can help those suffering from Asthma live a normal, active life.“

01ST

Register Today
Learn More

The first step is to learn more and see if you qualify. After registering, a clinical research coordinator will contact you and answer your questions
Sign up using the link below
Call or text +1 704 283 7359
02ND

Visit Our Center
See If You Qualify

Our facility is state of the art.

Visit our center for a prescreening visit to see if you qualify.

Our Address:
343 Venus Street, Monroe NC, 28112

Testimonials

What our Patients say about our services

Research facility

Monroe Biomedical

6300

Square feet Dedicated Research Facility

Cozy

Recreational Area Comfortable Recliners

Fun

Free entertainment options

Friendly

First Class Service from our Nurses and Staff

MBR Staff photo
MBR Staff photo
MBR Staff photo
MBR Staff photo

Free entertainment

Movies and Shows

Personal Tablets
Large Flatscreen TV

High Speed Wifi

Family Friendly

Very Comfortable
Recliners

ASTHMA

Ongoing Treatment Studies

Monroe Biomedical Research - Illustration - Clinical studies - Asthma

Monroe Biomedical Research is an FDA sanctioned clinical trial facility running multiple COPD treatment studies examining different ways to treat COPD.

ASTHMA TREATMENT STUDY
(LOGOS)

Age 12 to 80 years old
for patients who Have been diagnosed with Asthma for at least 12 months
therapy Budesonide, glycopyrronium, and formoterol fumarate compared to Symbicort
COMPENSATION Patients that qualify and choose to participate receive up to $1,125
Investigational Treatment

This study is examining whether an investigational medication called BGF MDI (a metered dose inhaler containing budesonide, glycopyrronium and formoterol fumarate) can improve asthma symptoms.

BGF MDI is an investigational orally inhaled combination of budesonide, glycopyrronium and formoterol fumarate, which is being compared to the Budesonide and Formoterol Fumarate Metered Dose Inhaler (BFF MDI) and Symbicort® pressurized Metered Dose Inhaler (Symbicort® pMDI).

Symbicort is a combination of budesonide and formoterol fumarate dihydrate and has already been approved for treatment of asthma in patients 6 years of age and older in the U.S.

For more information: click here
Included, at no cost
  • Study related visits
  • Physical Exams
  • Testing
  • Study Medication

ASTHMA TREATMENT STUDY
(VATHOS)

Age 12 to 80 years old
for patients who Have been diagnosed with Asthma for at least 6 months
therapy Budesonide and Formoterol Fumarate compared to Symbicort
COMPENSATION Patients that qualify and choose to participate receive up to $750
Investigational Treatment
(or Placebo)

The goal of this study is to have good control of asthma symptoms and minimize exacerbations. The study is examining the effectiveness of Budesonide and Formoterol Fumarate compared to Symbicort (which is an FDA approved product).

While Budesonide and Formoterol Fumarate are FDA approved active ingredients, the combination MDI investigational product is not yet FDA approved.

For more information: click here
Included, at no cost
  • Study related visits
  • Physical Exams
  • Testing
  • Study Medication

EOSINOPHILIC ASTHMA TREATMENT STUDY
(20033)

Age 18 years or older
for patients who Have been diagnosed with Asthma for at least 6 months
therapy Investigational Medication
COMPENSATION Patients that qualify and choose to participate receive compensation for their time and travel
Investigational Medication
(or Placebo)

This study is examining an investigational medication for treating eosinophilic asthma. This type of Asthma is persistent, can be moderate to severe, and is marked by high levels of white blood cells.

The purpose of this study is to evaluate an investigational medication in asthma patients compated to placebo while continuing with other asthma medications.

For more information: click here
Included, at no cost
  • Study related visits
  • Physical Exams
  • Testing
  • Study Medication

Contact Us

Monroe Biomedical Research
343 Venus Street, Monroe, NC 28112

Office Phone: 704-283-7369
Fax: 704-283-7329
Email: patients@monroeresearch.com

FAQ

Frequently Asked Questions

What is Asthma?
  • Asthma is a condition where the airways swell and narrow causing shortnes of breath and oftentimes excessive mucus.
How do I know if I have Asthma?
  • If you are suffering from Asthma, you may experience shortness of breath, wheezing, excessive mucus, chest tightness, or a lack of energy.
How much will the study cost?
  • There will be zero costs for the study participant to take part in the Asthma study.
What if I am uninsured?
  • Proof of insurance is NOT required to participate in this study. All medical oversight over the course of your study participation is included.
What does investigational medication mean?
  • An Investigational medication (also known as investigational new drug) has been approved by the Food and Drug Administration (FDA) for testing in people in a clinical study, but has not been approved for general use, distribution or sale. It is through clinical research that these medications receive full approval by the FDA.
How will I be compensated for participating?
  • Participants receive a check following each study visit. For this study, those that qualify and choose to participate could receive a total payment of up to $1,125.